julie brahmer, md, talks about the potential impact of immunotherapy in 1st line nsclc
Published 8 years ago • 32 plays • Length 0:41
Download video MP4
Download video MP3
Similar videos
-
1:32
david gandara, md, talks about the potential impact of immunotherapy in 1st line nsclc
-
0:35
david ettinger, md, talks about impact of immunotherapy in 1st line metastatic nsclc patients
-
1:21
julie brahmer, md, discusses considerations when choosing between immunotherapy and chemotherapy
-
1:00:52
immunotherapy for lung cancer: what patients need to know, with julie brahmer
-
1:31
dr. brahmer on the role of immunotherapy in metastatic nsclc
-
2:05
cancer immunotherapy in lung cancer discussed by dr. julie brahmer
-
0:58
dr. julie r. brahmer on immunotherapy development in lung cancer
-
1:32
dr. brahmer on the benefit of immunotherapy in metastatic nsclc
-
4:19
a new norm for skin cancer patients: dale’s immunotherapy story
-
13:11
understanding chemotherapy - jumo health
-
9:30
patient immunotherapy summit: pancreatic cancer brief
-
0:48
julie brahmer, md, on the level of pd-l1 expression in selecting the appropriate agent in nsclc
-
0:31
copy of dr. brahmer on the role of immunotherapy in metastatic nsclc
-
1:15
dr. brahmer on immunotherapy beyond pd-1/l1 in nsclc
-
0:35
julie brahmer, md, provides practical advice related to pd-l1 testing in nsclc patients
-
4:13
julie gralow, md, offers opinion on immunotherapy treatment trends in the management of tnbc
-
30:30
treatment talks | question and answer about immunotherapy
-
1:25
dr. brahmer discusses response to immunotherapy
-
26:02
doctors discuss: immunotherapy in lung cancer
-
1:56
dr. brahmer discusses the future of antibodies for lung cancer
-
3:42
immunotherapy: the revolution cancer care needs
-
6:04
harnessing the immune system to fight cancer
Clip.africa.com - Privacy-policy